Home » Topics » Conferences

Conferences
RSS

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Flavonoid intake reduces risk of death from CHD

March 4, 1998

Cyclopropane analogues as potent anti-HIV-1 agents

Feb. 26, 1998

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Feb. 25, 1998

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

Feb. 24, 1998

Nucleoside analogues from BioChem Therapeutic show potential for HIV/AIDS

Feb. 23, 1998

Immunosuppressive profile of activity of PS-64 extract

Feb. 17, 1998

Novel immunosuppressive extract magnifies the efficacy of ciclosporin in vitro

Feb. 17, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...